Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Blockade and Sugammadex in Laparoscopic Hysterectomy
NCT03519633Phase 2Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Apr 2018
- Primary completion
- Dec 2024
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Università Campus Bio-Medico di Roma. Started Apr 2018; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03519633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03519633.